Joan Connolly

Chief Technology Officer

Joan Connolly joins Albireo as Chief Technology Officer with extensive experience in biopharma commercial leadership including manufacturing management, product commercialization, and supply chain management. Prior to joining Albireo, Joan was the Senior Vice President of Technical Operations at Stemline Therapeutics where she led their product, ELZONRIS® (tagraxofusp-erzs) from Investigational New Drug (IND) stage through commercialization. Earlier in her career, Joan held senior roles at ImClone Systems and Bristol-Myers Squibb. She holds a bachelor’s degree in Chemical Engineering from Queen’s University.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Jason Duncan

Chief Legal Officer and General Counsel

Jan Mattsson, Ph.D.

Chief Scientific Officer, Managing Director (Sweden), and Co-Founder

Simon Harford

Chief Financial Officer

Patrick Horn, M.D., Ph.D.

Chief Medical Officer

Pamela Stephenson

Chief Commercial Officer

Michelle Graham

Chief Human Resources Officer

Joan Connolly

Chief Technology Officer